Nitric oxide: The 'second messenger' of insulin

IUBMB Life

Volumn 49, Issue 5, 2000, Pages 441-450

  Kahn, Nighat N ^a,b   Acharya, K ^c   Bhattacharya, S ^c   Acharya, R ^c   Mazumder, S ^c   Bauman, William A ^a,b   Sinha, Asru K ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JADAVPUR UNIVERSITY   (India)

Author keywords

L NAME; Nitric oxide synthase; Phosphatidylinositol 3 kinase; Red blood cells; Tyrosire kinase

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; SECOND MESSENGER;

ANIMALIA;

EID: 0033935883     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/152165400410308     Document Type: Article

References (29)

1. Czech, M. P. (1977) Molecular basis of insulin action. Annu. Rev. Biochem. 46, 359-493.
2. White, M. F., and Kahn, C. R. (1994) The insulin signaling system. J. Biol. Chem. 269, 1-4.
3. Kono, T., Robinson, F. W., Blevin, T. L., and Ezaki, O. (1982) Evidence that translocation of the glucose activity is the major mechanism of insulin action on glucose transport fat cells. J. Biol. Chem. 257, 10942-10947.
4. 1 binding to human platelet membrane by insulin and the activation of adenylate cyclase. J. Biol. Chem. 265, 4976-4981.
5. Clements, R. S. (1979) Diabetic neuropathy - new concepts of its etiology. Diabetes 28, 604-611.
6. Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuln, B. A., Silvennoinen, O., Ihle, J. N., and Carter-Su, C. (1993) Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
7. Weiss, A. (1993) T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73, 209-212.
8. Hayashi, T., Okamoto, M., Yoshimasa, Y., Inoue, G., Yamada, K., Kono, S., Shigemoto, J., Suga, J., Kuzurya, H., and Nakao, K. (1996) Insulin-induced activation of PI 3-kinase in Fao cells. Diabetologia 39, 515-522.
9. Fantus, I. G., George, R., Tang, S., Chong, P., and Poznansky, M. J. (1996) The insulin-mimetic agent vanadate promotes receptor endocytosis and inhibits intracellular ligand-receptor degradation by a mechanism distinct from the lysosomotropic agents. Diabetes 45, 1084-1093.
10. Hansen, P. A., Han, D. H., Marshall, B. A., Nolte, L. A., Chen, M. M., Mueckler, M., and Holloszy, J. O. (1998) A high-fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms. J. Biol. Chem. 273, 26157-36163.
11. 2. J. Biol. Chem. 262, 8252-8256.
12. Sinha, A. K., Bhattacharya, S., Acharya, K., and Mazumder, S. (1998) Administration of insulin prevents death due to thrombosis in mice. Ind. J. Physiol. Allied Sci. 52, 46-48.
13. Jia, L., Bonaventura, C., Bonaventura, J., and Stamler, S. J. (1996) S-Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380, 221-226.
14. 1. Biochim. Biophys. Acta 856, 421-427.
15. Gibson, D. D., Hornbrook, K. R., and McCay, P. B. (1980) Glutathione-dependent inhibition of lipid peroxidation by a soluble, heat labile factor in animal tissues. Biochim. Biophys. Acta 620, 572-582.
16. Cox, R. D., and Frank, C. W. (1982) Determination of nitrate and nitrite in blood and urine by chemiluminescence. J. Anal. Toxicol. 6, 148-152.
17. Scatchard, G. (1949) The attraction of proteins for small molecules and ions. Am. N.Y. Acad. Sci. 51, 666-672.
18. Karl, I.E., Gavin, J. R., and Levy, R. (1990) Effect of insulin on glucose utilization in epitrochlearis muscle of rats with streptozocin-induced NIDDM. Diabetes 39, 1106-1115.
19. Braun, S., Raymond, W. E., and Racker, E. (1984) Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J. Biol. Chem. 259, 2051-2054.
20. Arcaro, A., and Wyman, M. D. (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem. J. 296, 297-301.
21. Nakadate, T., Nakaki, T., Yamamoto, S., and Kato, R. (1983) Protection against alloxan-induced diabetes in mice by stimulation of alpha 2-adrenergic receptors. Life Sci. 32, 697-702.
22. Sinha, A. K., Bhattacharya, S., Acharya, K., Mazumder, S., Bauman W., and Kahn, N. N. (1998) Prevention of thrombosis in vivo by nitric oxide. Ind. J. Physiol. and Allied Sci. 52, 148-161.
23. Sakuma, I., Stuehr, D. J., Gross, S. S., Nathan, C., and Levi, R. (1988) Identification of a arginine a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A. 85, 8664-8667.
24. Zeng, G., and Quon, M. J. (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898.
25. Young, M. E., Radda, G. K., and Leighton, B. (1997) Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 322, 223-238.
26. Trovati, M., Anfossi, G., Massucco, P., Mattielo, L., Costamagna, C., Piretto, V., Mularoni, E., Cavalot, F., Bosia, A., and Ghigo, D. (1997) Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′,5′-cyclic monophosphate and adenosine-3′,5′-cyclic monophosphate. Diabetes 46, 742-749.
27. Bredt, D. S., and Snyder, S. H. (1990) Isolation of nitric oxide synthatase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87, 682-685.
28. Bredt, D. S., and Snyder, S. H. (1994) Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63, 175-195.
29. Little, S. A., and Ham, C. (1980) Effects of hydrogen peroxide on basal and hormone-stimulated lipolysis in perfused rat fat cells in relation to mechanism of action of insulin. J. Biol. Chem. 255, 10888-10895.